Study design
adenocarcinoma
METASTASES, ADENOCARCINOMA
The enrolled patients were at least 18 years old with newly diagnosed locally advanced (T1N1‐3M0 or T2‐3NanyM0), potentially resectable, and histologically or cytologically‐confirmed adenocarcinoma of distal esophagus, GEJ, and stomach. All participants were evaluated with CT chest/abdomen/pelvis (C/A/P), EUS, PET scan, and laparoscopy exams, and showed no evidence of distant metastases. All participants had to be eligible and physically fit to undergo curative surgical resection with ECOG performance status of 0 or 1. Participants had to meet the following laboratory parameters: hemoglobin ≥9/mm